Rapid Response for Psoriasis
November 17, 2016
Category: Home
Tags: Untagged

Study researcher Philip J. Mease, MD,  of the Swedish Medical Center and University of Washington in Seattle show tofacitinib is safely treating in patients with PsA in record time, read his findings.

Schedule an Appointment on ZocDoc

We have planned Special Holiday Thanks to Our Patients for a wonderful year! 

November 22nd, all-day pick-me-ups with Margene and 25% savings: RSVP here.

December 1st, Beautiful You Holiday Event to treat yourself for an evening: RSVP here

RSVP with a Call: 757-461-1033

Guide to Gorgeous Giving

Comments: